Skip to content

Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.

A Randomized and Controlled Study of Efficacy and Safety of Bovine Pericardial Patch and TiLOOP® Bra Mesh in Patients With Immediate Implant Breast Reconstruction.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04245930
Enrollment
176
Registered
2020-01-29
Start date
2020-01-01
Completion date
2022-12-31
Last updated
2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bovine Pericardial Patch, Implant Breast Reconstruction, TiLOOP® Bra Mesh

Brief summary

This study is the first randomized and controlled study assessing the efficacy and safety of bovine pericardial patch and TiLOOP® bra mesh in patients with immediate implant breast reconstruction

Interventions

PROCEDUREBovine Pericardial Patch in Immediate Implant Breast Reconstruction

Patients will receive immediate breast implant reconstruction using Bovine Pericardial Patch

PROCEDURETiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction

Patients will receive immediate breast implant reconstruction using TiLOOP® Bra Mesh

Sponsors

Tianjin Medical University Cancer Institute and Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Patients diagnosed with I\ II stage breast cancer and Intent to receive NSM or SSM and implant based breast reconstruction 2. Do not smoking in the last 4 weeks or more 3. Mental health patients 4. Signed consent to participate

Exclusion criteria

1. Locally advanced stage patients or patients with distal metastasis 2. Patients received thoracic wall radiotherapy or will receive radiotherapy 3. Smoking in the last 4 weeks 4. Anticipated implant volume more than 600cc 5. Patients of pregnancy or lactation 6. Patients received neoadjuvant therapy

Design outcomes

Primary

MeasureTime frameDescription
Complication Ratesup to 12 months after surgeryThe rate of complications in the two groups

Secondary

MeasureTime frameDescription
Cosmetic outcome of reconstructed breastImmediately, up to 3 months, 6 months and 12 months after surgeryHarris evaluation score was used to evaluate the aesthetic outcome of patients' reconstructed breasts, which was scored as excellent, good, fair, poor.
Patient satisfaction-Breast-Q questionnaireup to 12 months after surgeryWe use the Breast-Q questionnaire to evaluate patients' satisfaction via the reconstruction module of BREAST-Q.
The rate of surgical revision of reconstructed breastsup to 12 months after surgeryTo record the rate of surgical revision events of the reconstructed breasts
Health economics-inpatient costup to 12 months after surgery, including the cost of surgical revisionHospital inpatient costs due to immediate implant breast reconstruction

Countries

China

Contacts

Primary ContactChunyong Han, MD.
hancy_007@126.com+86-22-23340123
Backup ContactJian Yin, MD.
yinjian@tjmuch.com+86-22-23340123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026